A business case that stands up — clinically, commercially, operationally.
Medication-safety technology is easy to want and hard to justify. SAFERsleep gives you published outcomes, a proven supplier and a lower-risk implementation path to build the case on.
Request business-case support Our productsThe challenge
You’re asked to compare a paper process that looks free against systems with very different scopes and price tags — and to defend the decision later. That comparison needs more than a feature list.
Cost is the stated barrier
Upfront cost and funding are the most common reasons hospitals stay on paper — which makes the value story, not the price tag, the decision.
The case must be defendable
Committees need operational and safety value they can put in a business case, benchmarked fairly against alternatives.
Lifecycle risk is the hidden cost
Support, training, adoption failure and supplier reliability determine the real cost of ownership long after purchase.
The value case, beyond the price tag
SAFERsleep is purchasing-for-safety with a measurable return: fewer errors, better records, saved clinical time and a standardised process across sites.
- Published, quantified safety outcomes. A 35% relative reduction in parenteral drug errors and a 21% lower overall error rate — evidence most alternatives simply don’t have.
- Operational value you can count. Faster record retrieval, less clinician time on documentation, and legible records that reduce downstream audit and coding friction.
- A lower-risk implementation. Structured, project-managed installation with training minimised — protecting the benefit your business case depends on.
- A supplier that stays. Two decades supplying NZ and UK hospitals, with responsive long-term support and an established consumables and label-ordering service.
The evidence
SAFERsleep is one of the few anaesthesia medication-safety systems whose results have been measured and published in peer-reviewed clinical studies.
relative reduction in parenteral drug errors in a large incident-monitoring study — from 0.049 to 0.032 errors per administration.
lower overall error rate in a randomised clinical evaluation — mean errors fell from 11.6 to 9.1 per 100 administrations.
to retrieve specified information from a SAFERsleep record, versus 3m 41s from conventional records.
Independent, peer-reviewed evaluations — comparison-ready evidence for option appraisal.
Your questions, answered
Q.What is the ROI?
The return comes from avoided medication-error harm and its costs, clinician time released from documentation, and standardisation across theatres. We’ll help you model it on your own case volumes as part of business-case support.
Q.Is this safer enough to justify the spend?
That’s a question the published evidence answers directly: 35% relative reduction in parenteral drug errors in incident monitoring, 21% lower overall error rate in randomised evaluation. Few purchases in your portfolio come with that level of proof.
Q.What are the total lifecycle and support costs?
Pricing is transparent: system, implementation, training, ongoing support and consumables (including drug labels) are all defined up front, so there’s no year-three surprise.
Q.Is this a local clinical preference or a broader hospital need?
Both — which is what makes it fundable. Clinicians want it for usability; the hospital case rests on safety, governance, audit-readiness and standardisation. This page’s siblings give each stakeholder their own answer.
What you’re buying, defined up front
Transparent scope
System, installation, training, support and consumables specified clearly for fair comparison and evaluation.
Proven supplier
SAFERsleep has supplied public and private hospitals in New Zealand and the UK for over 20 years.
Sustained value
Long-term support with regular service reviews protects adoption — and the return — over the asset’s life.
We chose the SAFERsleep system after exhaustively searching the market for an electronic anaesthetic record keeping system. No competitor came close to matching the reliability, ease of use and built-in drug administration safety features that SAFERsleep offered.
Trusted by hospitals in New Zealand and the UK
Build the business case with us
We’ll supply the evidence pack, reference customers, and cost-and-value framework your committee needs for a fair option appraisal.
Request business-case supportInformation for other roles
Every member of the evaluation team sees SAFERsleep differently. Share the page that answers their questions. See all roles →
Safer medication practice and clearer records — without adding friction in theatre.
Measurable medication-safety improvement, stronger traceability and audit-ready records.
A supportable, interoperable solution that fits hospital systems and real constraints.
A strategic, scalable safety and governance improvement for the whole perioperative pathway.